Oncternal Therapeutics to Report Second Quarter 2019 Financial Results and Provide Business Update

SAN DIEGO, Aug. 01, 2019 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biotechnology company developing potential first-in-class product candidates for cancers with critical unmet medical need, today announced that it will report second quarter 2019 financial results after the market closes on?Thursday, August 8, 2019. Oncternal?s management will host a webcast and conference call at?2:00 p.m. PDT (5:00 p.m. EDT) to discuss the Company?s financial results and provide a comprehensive business update.